sprite-preloader
Anzeige
Mehr »
Montag, 23.04.2018 Börsentäglich über 12.000 News von 574 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrDicerna shares rocket up on a $15M-plus-stock deal to settle Alnylam claims
FrAfter fruitless talks, a bid from Vas and plenty of patience, AveXis CEO Sean Nolan slowly reeled in an $8.7B deal
FrPressing for direct negotiations, Takeda adds cash to a meatier $63B bid to buy Shire
FrHong Kong clears way for pre-revenue biotech IPOs, plans to accept listing applications by May
FrArcturus takes another legal stab at former CEO as public battle turns serious for the company
FrJohn Orwin tapped to lead Atreca; John Tsai takes Vas Narasimhan's old role at Novartis; Hal Barron nabs Genentech's Kevin Sin
FrNovartis CEO Vas Narasimhan is raising the bar on second-gen cancer drug studies
FrWith Gilenya generics looming, Novartis' siponimod team buffs up the MS data package being prepped for the FDA
FrCHMP scolds AB Science (again) for masitinib shortcomings, triggering a new rout on stock price
FrUCB snags an NDA-ready epilepsy drug from Proximagen in $370M deal
FrBiogen pays $1B cash to enlist Ionis on a new drug discovery campaign - but can it deliver fast enough for analysts?
DoOn second thought, Allergan doesn't want to consider a bid for Shire, leaving Takeda in sole pursuit of $62.5B deal
DoGW Pharma walks away from adcomm with unanimous support for anti-seizure med. An OK shouldn't take long now
DoTocagen licenses immunotherapy to ApolloBio for $16M upfront; WuXi AppTec unveils expanded lab testing site in New Jersey
DoBiotech unicorn's 'brain' attracts a $115M mega-round as investors embrace AI upstart
DoIn knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
DoShire rejects a $62.5B offer as Takeda circles with three swift buyout bids
DoFDA's insider review raises serious safety issues as Eli Lilly's quick comeback shot for baricitinib heads for expert showdown
DoKleiner Perkins' Beth Seidenberg bumps Tmunity's cell therapy round to a cool $135M
DoBadrul Chowdhury jumps ship at the FDA and moves to AstraZeneca, joining an exodus of agency officials
DoNovartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a $9B organization
DoAstraZeneca wins expanded OK to use Tagrisso in frontline lung cancer niche, spurring hope of hitting $3B sales goal
DoBluebird's gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
MiFull FDA letter in hand, Solid Bio says it's working to reverse clinical hold on its DMD gene therapy
MiSanofi CFO Jerome Contamine hits the exit; Struggling Fibrocell triggers a strategic review